article thumbnail

Therapy Dogs Can Ease Nurses', Doctors' Stress, Too

Drugs.com

18, 2024 -- Therapy dogs can help boost the spirits of health care workers in the same way they brighten the moods of hospital patients, a new study shows. WEDNESDAY, Sept. The furry, four-legged friends reduced emotional exhaustion and job stress.

Nurses 242
article thumbnail

New data underline cancer risk of Bluebird therapy for brain disease

BioPharma Drive: Drug Pricing

Seven young boys given Bluebird's Skysona later developed blood cancers, findings that could shape how doctors balance the gene therapy’s risks against its benefit.

Therapies 177
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sage offers details on launch of new postpartum depression pill

BioPharma Drive: Drug Pricing

The company and partner Biogen say signs from payers and doctors suggest the launch of Zurzuvae, the first oral therapy for PPD, is off to a good start.

Doctors 306
article thumbnail

Combination Therapy Recommended For Migraines

Drugs.com

THURSDAY, March 20, 2025 -- Doctors should prescribe triptans for migraine patients who arent receiving relief from over-the-counter (OTC) pain relievers, according to a new clinical guideline from the American College of Physicians.The r.

Therapies 174
article thumbnail

At ASH, doctors acclaim new sickle cell gene therapies, but are cautious on details

BioPharma Drive: Drug Pricing

Uptake of Casgevy and Lyfgenia may be slow despite their dramatic benefit, physicians said, citing complexities in treatment, manufacturing and reimbursement.

Doctors 177
article thumbnail

Altasciences at ASGCT 2025: An Open Forum for All Things Gene and Cell Therapy | By Kaylyn Koenig

Alta Sciences

Altasciences at ASGCT 2025: An Open Forum for All Things Gene and Cell Therapy | By Kaylyn Koenig aasimakopoulos Thu, 07/10/2025 - 08:00 I recently returned from attending the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting. WHO WAS AT ASGCT 2025?

article thumbnail

What FDA’s Newest Gene Therapy Approval Tells Us About Durability: How Long is Long Enough?

FDA Law Blog: Drug Discovery

Valentine — On November 22, 2022, FDA approved CSL Behring’s BLA for Hemgenix (etranacogene dezaparvovec), an AAV-based gene therapy for the treatment of adults with Hemophilia B who currently use Factor IX prophylaxis therapy, have current or historical life-threatening hemorrhage, or have repeated, serious spontaneous bleeding episodes.

Therapies 119